CN Patent

CN1780634A — 应用促性腺激素释放激素的组合物和方法

Assigned to Debiopharm SA · Expires 2006-05-31 · 20y expired

What this patent protects

本发明涉及包含两种缓释制剂的组合物，第一种能够释放促性腺激素释放激素组分，第二种能够释放雌激素组分。本发明的组合物可以用于前列腺癌的改进性雄性激素消除治疗，在治疗的过程中通过维持较低的足够的雌激素水平来最小化骨矿物质密度损耗和热潮红发生的频率及严重性。

USPTO Abstract

本发明涉及包含两种缓释制剂的组合物，第一种能够释放促性腺激素释放激素组分，第二种能够释放雌激素组分。本发明的组合物可以用于前列腺癌的改进性雄性激素消除治疗，在治疗的过程中通过维持较低的足够的雌激素水平来最小化骨矿物质密度损耗和热潮红发生的频率及严重性。

Drugs covered by this patent

Patent Metadata

Patent number
CN1780634A
Jurisdiction
CN
Classification
—
Expires
2006-05-31
Drug substance claim
No
Drug product claim
No
Assignee
Debiopharm SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.